These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23428698)

  • 1. Interaction between weight and medications in psychological illnesses of children.
    Apter A; Steingart L
    World Rev Nutr Diet; 2013; 106():174-80. PubMed ID: 23428698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight gain associated with use of psychotropic medications.
    Sachs GS; Guille C
    J Clin Psychiatry; 1999; 60 Suppl 21():16-9. PubMed ID: 10548137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacology in the treatment of anorexia nervosa and bulimia nervosa.
    Hoffman L; Halmi K
    Psychiatr Clin North Am; 1993 Dec; 16(4):767-78. PubMed ID: 7906029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain--as possible predictor of metabolic syndrome.
    Grahovac T; Ružić K; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
    Psychiatr Danub; 2011 Mar; 23(1):105-7. PubMed ID: 21448110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
    Maayan L; Correll CU
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin for weight loss and control in patients with mood disorder.
    Linneke JL; Jørgensen GK; Csillag C
    J Clin Psychiatry; 2014 Oct; 75(10):e1140-1. PubMed ID: 25373124
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted intervention to improve monitoring of antipsychotic-induced weight gain and metabolic disturbance in first episode psychosis.
    Thompson A; Hetrick SE; Alvarez-Jiménez M; Parker AG; Willet M; Hughes F; Gariup M; Gomez DL; McGorry PD
    Aust N Z J Psychiatry; 2011 Sep; 45(9):740-8. PubMed ID: 21827345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic issues in psychotic disorders with the focus on first-episode patients: a review.
    Britvic D; Maric NP; Doknic M; Pekic S; Andric S; Jasovic-Gasic M; Popovic V
    Psychiatr Danub; 2013 Dec; 25(4):410-5. PubMed ID: 24247054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antipsychotic agents and weight gain].
    Raaska K
    Duodecim; 2002; 118(2):157-62. PubMed ID: 12229110
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of antipsychotic medications on microbiome and weight gain in children and adolescents.
    Bretler T; Weisberg H; Koren O; Neuman H
    BMC Med; 2019 Jun; 17(1):112. PubMed ID: 31215494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic-associated weight gain and clinical outcome parameters.
    Blin O; Micallef J
    J Clin Psychiatry; 2001; 62 Suppl 7():11-21. PubMed ID: 11346191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychotropic drugs and diabetes].
    Ress C; Tschoner A; Kaser S; Ebenbichler CF
    Wien Med Wochenschr; 2011 Nov; 161(21-22):531-42. PubMed ID: 21792529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight gain in the treatment of mood disorders.
    Aronne LJ; Segal KR
    J Clin Psychiatry; 2003; 64 Suppl 8():22-9. PubMed ID: 12892538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of anorexia nervosa: a retrospective study in preadolescents and adolescents.
    Rossi G; Balottin U; Rossi M; Chiappedi M; Fazzi E; Lanzi G
    Clin Pediatr (Phila); 2007 Nov; 46(9):806-11. PubMed ID: 17641118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric medication induced obesity: an aetiologic review.
    Virk S; Schwartz TL; Jindal S; Nihalani N; Jones N
    Obes Rev; 2004 Aug; 5(3):167-70. PubMed ID: 15245385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced hyperphagia: what can we learn from psychiatric medications?
    Jensen GL
    JPEN J Parenter Enteral Nutr; 2008; 32(5):578-81. PubMed ID: 18753398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic treatment of delusions.
    Opler LA; Klahr DM; Ramirez PM
    Psychiatr Clin North Am; 1995 Jun; 18(2):379-91. PubMed ID: 7659605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide-induced weight loss in schizophrenia: case series.
    Yang J; Lee MS; Joe SH; Jung IK; Kim SH
    Clin Neuropharmacol; 2010; 33(2):104-6. PubMed ID: 19935403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.